Feedback / Questions
axitinib intradermal (AIV001) - AiViva BioPharma
https://www.globenewswire.com/news-release/2024/12/09/2993633/0/en/AiViva-Biopharma-Receives-FDA-Clearance-to-Administer-AIV001-in-Facial-Skin-by-Intradermal-Injection-for-Nonmelanoma-Skin-Cancer.html
Dec 9, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next